ALNY vs FCUV · P/E 76, rev $1.29B vs rev $723.1K
Alnylam Pharmaceuticals Inc (ALNY) versus Focus Universal Inc (FCUV) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Focus Universal Inc (FCUV) is a scientific & technical instruments company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported FCUV revenue for 2026-06-30 was $723.1K. Net income was -$2.8M. FCUV currently screens at market cap $1.9M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. FCUV currently screens at market cap $1.9M.
Not investment advice. Open the ALNY and FCUV stock pages for the full models.
Not investment advice.